2-Cycloheptyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

3-Hidroxibenzaldehído, mínimo 97%, para síntesis, 100 g, envase de plástico.

Ethyl 3-methoxy-1H-pyrazole-4-carboxylate, 95.0%, 25g

(E)-ETHYL 3-(1-METHYL-1H-PYRAZOL-4-YL)ACRYLATE, 95.0%, 250mg

Piceid>95.0%(HPLC)1g

2-Bromo-4-chloro-5-fluorothiophenol, 98%, 1g

4-(2-(Piperidin-1-yl)ethoxy)benzoic acid hydrochloride, 95.0%, 25g

4-chloro-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 250mg

[S(R)]-N-[(1S)-1-[3',5'-Bis(1,1-dimethylethyl)[1,1'-biphenyl]-2-yl]-2-(diphenylphosphino)ethyl]-2-methyl-2-propanesulfinamide, 95%, 50mg

(R)-2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid, 97%, 250mg

2-Amino-3-nitrophenol>98.0%(HPLC)(T)25g

IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID, 8-BROMO-1,5-DIHYDRO-, ETHYL ESTER, 95.0%, 250mg

Methyl 2-(2,6-dichloropyrimidin-4-yl)acetate, 95+%, 1g